BraveCX
Overview
BraveCX by Bering Limited is an FDA 510(k) cleared artificial intelligence (AI) powered chest X-ray triage solution. It is designed as a radiological computer-assisted triage and notification software that analyzes adult (≥18 years old) chest X-ray images for the presence of pre-specified suspected critical findings, specifically pleural effusion and pneumothorax.
The tool integrates seamlessly into existing clinical workflows, providing case-level outputs in the PACS/workstation for worklist prioritization or triage. It aims to enhance safety and efficiency in emergency departments by flagging suspicious images, thereby enabling clinicians to prioritize patients with target indications and reducing the time-to-diagnosis of urgent cases. BraveCX acts as a ‘second opinion’ for physicians, without providing direct diagnostic decisions.
Developed on over 1,000,000 chest X-rays acquired across diverse clinical settings and further fine-tuned with over 50,000 CXRs labeled by board-certified radiologists, BraveCX demonstrates high performance with 95%-97% specificity and ROC AUCs of 0.96 for pleural effusion and 0.98 for pneumothorax. Results are typically available in under 10 seconds.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- FDA 510(k) Cleared for Chest X-Ray Triage
- Detects Pleural Effusion and Pneumothorax
- Superior Accuracy (95-97% specificity, ROC AUCs 0.96/0.98)
- Fast Triage Results (under 10 seconds)
- Integrates with PACS/Workstation
- Flexible Deployment (Cloud, On-Premise, Hardware Integration)
- Automated Quality Control
- Prioritizes Cases in Worklist
- Trained on over 1,000,000 CXRs
- Clinical Decision Support for Radiologists
Use Cases
- Enhance safety and efficiency in emergency departments
- Reduce time-to-diagnosis for urgent chest X-ray findings
- Optimize radiologist workflow and prioritization
- Provide a 'second opinion' for physicians on critical findings
- Support proactive patient care in acute settings
What Physicians Need to Know
Leverage BraveCX as a rapid triage tool for adult chest X-rays, particularly in high-volume settings, to quickly identify and prioritize urgent cases like pleural effusion and pneumothorax. While it provides a valuable 'second opinion,' always integrate its findings with your comprehensive clinical assessment and patient history. The system's high specificity and AUC values suggest reliable performance for its intended purpose.
BraveCX is designed for versatile integration, supporting cloud, on-premises, and direct hardware integrations. This flexibility allows for seamless incorporation into various existing radiology workflows and IT infrastructures, minimizing disruption and maximizing accessibility at the point of care.
Details
| Category | Radiology & Imaging AI, Triage & ER/ICU AI |
| Pricing | Contact vendor — Custom pricing based on deployment and usage; contact vendor for details. |
| Deployment | Cloud, On-Premise, Integrated with CXR hardware systems |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Yes AI-estimated BraveCX received U.S. Food and Drug Administration (FDA) 510(k) clearance (K223754) around December 2023. It is cleared as a radiological computer-assisted triage and notification software for adult chest X-ray images to detect suspected pleural effusion and pneumothorax. |
| Integrations | |
| EHR | Not specified |
| Specialties | Emergency Medicine, Radiology |
Ratings & Reviews
Rate BraveCX
Press & Coverage
Frequently Asked Questions
Compare BraveCX
VS
VS
VS
VS
Investors who backed BraveCX
Funded through the company that built this tool.
